Inactive Instrument

Other languages Strongbridge Biopharma

Equities

SBBP

IE00BYZ5XL97

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Strongbridge Biopharma : Says Glass Lewis Recommends Shareholders Vote in Favor of Proposed Deal with Xeris	21-08-31
Xeris Pharmaceuticals : ISS Recommends Xeris, Strongbridge Shareholders Vote in Favor of Proposed Deal	21-08-30
Strongbridge Biopharma : Earnings Flash (SBBP) STRONGBRIDGE BIOPHARMA Posts Q2 Revenue $10M, vs. Street Est of $8.89M	21-08-05
Strongbridge Biopharma plc Revises KEVEYIS Revenue Guidance for the Full Year 2021	21-08-05
Strongbridge Biopharma : Receives US Patent for Treating Cushing's Syndrome with Recorlev in Certain Diabetics	21-06-03
"L'environnement est toujours favorable à la stratégie", souligne Laffitte Risk Arbitrage	21-06-02
Xeris Pharmaceuticals : to Buy Strongbridge Biopharma in $267 Million Deal	21-05-24
Strongbridge Biopharma : New Drug Application for Recorlev Accepted by FDA For Review	21-05-13
Strongbridge Biopharma : Earnings Flash (SBBP) STRONGBRIDGE BIOPHARMA Posts Q1 Revenue $8.4M, vs. Street Est of $8.31M	21-05-12
Strongbridge Biopharma plc Reiterates Revenue Guidance for the Full Year 2021	21-05-12
Strongbridge Biopharma plc Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-12
Strongbridge Biopharma : Recorlev Shows Benefits in Cushing's Syndrome Trial	21-04-07
Strongbridge Biopharma plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2020	21-03-03
Strongbridge Biopharma : Earnings Flash (SBBP) STRONGBRIDGE BIOPHARMA Reports Q4 Revenue $8.2M, vs. Street Est of $8.2M	21-03-03
Strongbridge Biopharma : Seeks FDA Approval for Recorlev as Potential Treatment of Endogenous Cushing's Syndrome	21-03-02
Strongbridge Biopharma : Appoints Richard Kollender as President, CFO	21-02-16
Strongbridge Biopharma plc Provides Revenue Guidance for the Full Year 2021	21-01-06
Strongbridge Biopharma plc Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-10-29
Strongbridge Biopharma plc Reiterates Revenue Guidance for the Full Year of 2020	20-10-29
Strongbridge Biopharma Reports Revenue Guidance for the Full Year Ended 2020	20-08-04

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Strongbridge Biopharma

Equities

SBBP

IE00BYZ5XL97

Other languages

Filters